CRIS
Curis Inc
$0.35
-0.07 (-16.67%)
At close · Jul 2
Market Cap
$13.51M
Shares
38,978,693
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.35
Open$0.44
Day$0.34–0.45
52W$0.18–2.01
Avg vol 30d5.7M
Short int262K · 0.7% float · 1.4d
Short vol46%
Last earningsMay 12, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 13
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−64% below
−
Price vs 50-day avg
−29% below
◦
RSI (14)
44 · neutral
+
MACD trend
positive
−
52-week position
9% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $0 › 200d $1 — 200d above 50d
+
Institutional flow
+2% holders QoQ · +11 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.67% of float · ▼ -7.7% MoM · 1.4 days cover
◦
Volume signal
Volume near normal
+
Institution breadth
42 holders — near 3-yr high, broad support
Fundamentals
Strong
+
Revenue growth
+31% Y/Y
+
EPS growth
+92% Y/Y
−
Free cash flow
$-27.2M
◦
Balance sheet
net debt $2.8M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 12, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−64% below
Bearish
Price vs 50-day avg
−29% below
Bearish
RSI (14)
44 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
9% · near low
Bearish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+2% holders QoQ · +11 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.67% of float · ▼ -7.7% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
42 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $0
Now $0 · 9%
52-wk high $2
vs 200-day avg -64%
vs 50-day avg -29%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CRIS
this stock
Curis Inc
|
$13.51M | -64.6% | +31.5% | — | 0.7% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CRIS | +66.7% | -30.0% | -58.8% | -32.7% | -64.7% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +65.2% | -28.8% | -66.8% | -32.4% | -73.9% |